Modelling phase transition kinetics of chenodeoxycholic acid with the Runge-Kutta method

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 1, 2010, Pages 7-14

  Petkune, Sanita ^a   Actins, Andris ^a  

^a UNIVERSITY OF LATVIA   (Latvia)

Author keywords

Chenodeoxycholic acid; Drug polymorphism; Kinetics of polymorphs; Runge Kutta method; X ray diffraction

Indexed keywords

CHENODEOXYCHOLIC ACID;

ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CRYSTALLIZATION; DRUG STABILITY; DRUG STRUCTURE; HIGH TEMPERATURE PROCEDURES; HUMIDITY; KINETICS; LOW TEMPERATURE PROCEDURES; MATHEMATICAL COMPUTING; PHASE TRANSITION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; STRUCTURE ANALYSIS; TEMPERATURE SENSITIVITY; X RAY DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CHENODEOXYCHOLIC ACID; CRYSTALLIZATION; DIFFERENTIAL THERMAL ANALYSIS; DRUG STABILITY; KINETICS; MODELS, STATISTICAL; PHASE TRANSITION; SPECTROPHOTOMETRY, INFRARED; TEMPERATURE; X-RAY DIFFRACTION;

EID: 77952320183     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.02.038     Document Type: Article

References (14)

1. Vippagunta S.R., Brittain H.G., Grant D.J.W. Crystalline solids. Drug Deliv. Rev. 2001, 48:3-26.
2. Kato F., Otsuka M., Matsuda Y. Kinetic study of the transformation of mefenamic acid polymorphs in various solvents and under high humidity conditions. Int. J. Pharm. 2006, 321:18-26.
3. Nemet Z., Csonka Kis G., Pokol G., Demeter A. Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study. J. Pharm. Biomed. Anal. 2009, 49:338-346.
4. Oguchi T., Sasaki N., Hara T., Tozuka Y., Yamamoto K. Differentiated thermal crystallization from amorphous chenodeoxycholic acid between the ground specimens derived from the polymorphs. Int. J. Pharm. 2003, 253:81-88.
5. Guiseppetti G., Paciotti M. Polymorphism of chenodeoxycholic acid. Farmaco Educ. Sci. 1978, 33:64-72.
6. Alvarez M., Jover A., Carrazana J., Meijide F., Soto V.H., Vazquez Tato J. Crystal structure of chenodeoxycholic acid, ursodeoxycholic acid and their two 3β,7α- and 3β,7β-dihydroxy epimers. Steroids 2007, 72:535-544.
7. Stephenson G.A., Stowell J.G., Toma P.H., Dorman D.E., Greene J.R., Byrn S.R. Solid-state analysis of polymorphic, isomorphic, and solvated forms of dirithromycin. J. Am. Chem. Soc. 1994, 116:5766-5773.
8. Lindley P.F., Mahmoud M.M., Watson F.E., Jones W.A. The structure of chenodeoxycholic acid, C24H4004. Acta Cryst. 1980, B36:1893-1897.
9. 4, determined with synchrotron radiation. Acta Crystallogr. 1990, B46:262-266.
10. Stephenson G.A., Forbes R.A., Reutzel-Edens S.M. Characterization of the solid state: quantitative issues. Adv. Drug Deliv. Rev. 2001, 48:67-90.
11. Campbell Roberts S.N., Williams A.C., Grimsey I.M., Booth S.W. Quantitative analysis of mannitol polymorphs. X-ray powder diffractometry-exploring preferred orientation effects. J. Pharm. Biomed. Anal. 2002, 28:1149-1159.
12. Zhu H., Xu J., Varlashkin P., Long S., Kidd C. Dehydration, hydration behavior, and structural analysis of fenoprofen calcium. J. Pharm. Sci. 2000, 90:845-859.
13. Urakami K., Beezer A.E. A kinetic and thermodynamic study of seratrodast polymorphic transition by isothermal microcalorimetry. Int. J. Pharm. 2003, 257:265-271.
14. Huberty J., Xu H. Kinetic study on phase transformation from titania polymorph brookite to rutile. J. Solid State Chem. 2008, 181:508-514.